Phase I/II trial of cyclosporine as a chemotherapy-resistance modifier in acute leukemia. [electronic resource]
Producer: 19930923Description: 1652-60 p. digitalISSN:- 0732-183X
- ATP Binding Cassette Transporter, Subfamily B, Member 1
- Acute Disease
- Adolescent
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- pharmacokinetics
- Carrier Proteins -- genetics
- Child
- Child, Preschool
- Cyclosporine -- adverse effects
- Daunorubicin -- administration & dosage
- Drug Resistance -- genetics
- Female
- Gene Expression
- Humans
- Leukemia, Myeloid -- blood
- Male
- Membrane Glycoproteins -- genetics
- Middle Aged
- Neoplasm Proteins -- genetics
- Phenotype
- Survival Analysis
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.